ScoreWhy is Sudeep Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0% over the last 5 years
2
Positive results in Mar 26
- NET SALES(Q) Highest at Rs 182.34 cr
- PBDIT(Q) Highest at Rs 62.59 cr.
- PBT LESS OI(Q) Highest at Rs 56.27 cr.
3
With ROE of 19.6, it has a Very Expensive valuation with a 8.9 Price to Book Value
4
Majority shareholders : Promoters
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sudeep Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
33.98
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.65
Tax Ratio
23.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.46%
ROCE (avg)
24.88%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
69
Industry P/E
36
Price to Book Value
14.31
EV to EBIT
61.20
EV to EBITDA
57.11
EV to Capital Employed
13.79
EV to Sales
19.73
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
22.53%
ROE (Latest)
19.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
PAT(9M)
At Rs 136.89 cr has Grown at 31.99%
NET SALES(Latest six months)
At Rs 340.61 cr has Grown at 20.58%
-3What is not working for the Company
INTEREST(Latest six months)
At Rs 4.50 cr has Grown at 30.43%
PAT(Q)
At Rs 40.55 cr has Fallen at -6.2% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Sudeep Pharma
Net Sales - Latest six months
At Rs 340.61 cr has Grown at 20.58%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Sudeep Pharma
Interest - Latest six months
At Rs 4.50 cr has Grown at 30.43%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Quarterly
At Rs 40.55 cr has Fallen at -6.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 43.23 CrMOJO Watch
Near term PAT trend is negative
PAT (Rs Cr)
